Clinical Trial Update: A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 long-term study evaluating pregabalin for postherpetic neuralgia completed; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuralgia, Postherpetic | Phase 3 | Status: COMPLETED | Results posted: 2009-09-28